Atlas Trials

Chronic Stable Illness

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Stable Illness

RecordFirmDate
COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers (NCT05181683)Regeneron Pharmaceuticals2022-01-07
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers (NCT04852978)Regeneron Pharmaceuticals2021-04-29
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 (NCT04519437)Regeneron Pharmaceuticals2020-07-26

Track Chronic Stable Illness automatically

Every clearance here is in the API, with alerts when new ones post.